Skip to main content

Duricef Side Effects

Generic name: cefadroxil

Medically reviewed by Drugs.com. Last updated on Dec 3, 2023.

Note: This document contains side effect information about cefadroxil. Some dosage forms listed on this page may not apply to the brand name Duricef.

Applies to cefadroxil: oral capsule, oral powder for suspension, oral tablet.

Serious side effects of Duricef

Along with its needed effects, cefadroxil (the active ingredient contained in Duricef) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking cefadroxil:

Rare

Incidence not known

Other side effects of Duricef

Some side effects of cefadroxil may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Rare

Incidence not known

For Healthcare Professionals

Applies to cefadroxil: oral capsule, oral powder for reconstitution, oral tablet.

Gastrointestinal

Mild to life-threatening pseudomembranous colitis has been reported in patients given this drug; this side effect may occur during or after treatment.[Ref]

Common (1% to 10%): Abdominal discomfort, abdominal pain, diarrhea, dyspepsia, glossitis, nausea, vomiting

Very rare (less than 0.01%): Pseudomembranous colitis

Frequency not reported: Colitis[Ref]

Dermatologic

Common (1% to 10%): Allergic exanthema, pruritus, rash, urticaria

Very rare (less than 0.01%): Erythema multiforme, Stevens-Johnson syndrome

Frequency not reported: Toxic epidermal necrolysis[Ref]

Immunologic

Uncommon (0.1% to 1%): Opportunistic organism/fungal growth, thrush

Rare (0.01% to 0.1%): Serum sickness, serum sickness-like reactions

Frequency not reported: Superinfection[Ref]

Genitourinary

Uncommon (0.1% to 1%): Genital candidiasis/genital moniliasis/vaginal mycoses

Rare (0.01% to 0.1%): Genital pruritus, vaginitis[Ref]

Hematologic

Agranulocytosis, eosinophilia, leukopenia, neutropenia, and/or thrombocytopenia occurred during prolonged treatment, but usually subsided upon discontinuation of treatment.[Ref]

Rare (0.01% to 0.1%): Agranulocytosis, eosinophilia, leukopenia, moderate transient neutropenia/neutropenia, thrombocytopenia

Very rare (less than 0.01%): Direct/indirect positive Coombs tests, hemolytic anemia (immunologic origin)

Frequency not reported: Aplastic anemia, pancytopenia, prolonged prothrombin time[Ref]

Hypersensitivity

Rare (0.01% to 0.1%): Angioneurotic edema/angioedema

Very rare (less than 0.01%): Anaphylactic shock, immediate allergic reaction

Frequency not reported: Allergies, anaphylaxis[Ref]

Allergies included anaphylaxis, angioedema, pruritus, rash, and urticaria. Most allergy symptoms subsided upon treatment discontinuation.[Ref]

Other

Rare (0.01% to 0.1%): Drug fever/fever

Very rare (less than 0.01%): Fatigue[Ref]

Hepatic

Rare (0.01% to 0.1%): Liver dysfunction

Very rare (less than 0.01%): Cholestasis, idiosyncratic liver failure, minor transaminase elevations (ALT, AST, alkaline phosphatase)

Frequency not reported: Elevated bilirubin[Ref]

Renal

Rare (0.01% to 0.1%): Interstitial nephritis

Frequency not reported: Increased blood urea nitrogen (BUN), increased creatinine, renal dysfunction, toxic nephropathy[Ref]

Musculoskeletal

Rare (0.01% to 0.1%): Arthralgia[Ref]

Nervous system

Very rare (less than 0.01%): Dizziness, headache, sleeplessness

Frequency not reported: Seizures[Ref]

Metabolic

Frequency not reported: Elevated lactate dehydrogenase (LDH)[Ref]

Cardiovascular

Frequency not reported: Hemorrhage[Ref]

Psychiatric

Very rare (less than 0.01%): Nervousness[Ref]

Frequently asked questions

References

1. Product Information. Duricef (cefadroxil). Bristol-Myers Squibb. 2002;PROD.

2. Cerner Multum, Inc. UK Summary of Product Characteristics.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.